Mitochondrial disorders: Methods and specimen selection for diagnostic molecular pathology

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 6, 1996, Pages 597-603

  Kiechle, Frederick L ^a   Kaul, Karen L ^b   Farkas, Daniel H ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; RIBOSOME RNA; TRANSFER RNA;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; GENE DELETION; GENE DUPLICATION; HUMAN; MOLECULAR GENETICS; NUCLEIC ACID BASE SUBSTITUTION; SAMPLING; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE PREPARATION;

DNA, MITOCHONDRIAL; HUMANS; MERRF SYNDROME; MITOCHONDRIA; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MOLECULAR BIOLOGY; MUTATION; SPECIMEN HANDLING;

EID: 0030013665     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Kiechle FL, Quattrociocchi-Longe TM. The role of the molecular probe laboratory in the 21st century. Lab Med. 1992;23:758-763.
2. DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993.
3. Wallace DC, Lott MT, Torroni A, Shoffner JM. Report of the committee on human mitochondrial DNA. Cytogenet Cell Genet. 1991;58:1103-1123.
4. Wallace DC. Disease of the mitochondrial DNA. Annu Rev Biochem. 1992;61:1175-1212.
5. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994;91:10771-10778.
6. Pinz KG, Shibutani S, Bogenhagen DF. Action of mitochondrial DNA polymerase δ at sites of base loss or oxidative damage. J Biol Chem. 1995;270:9202-9206.
7. Marzuki S, Noer AS, Lertrit P, et al. Normal variants of human mitochondria! DNA and translation products: the building of a reference data base. Hum Genet. 1991;88:139-145.
8. Lestienne P, Bataille N. Mitochondrial DNA alterations and genetic diseases: a review. Biomed Pharmacother. 1994;48:199-214.
9. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases: disorder of two genomes. Adv Hum Genet. 1990;19:267-330.
10. Herzberg NH, Middelkoap E, Adorf M, et al. Mitochondria in cultured human cells depleted of mitochondrial DNA. Eur. J Cell Biol. 1993;61:400-408.
11. Virbasius JV, Scarpulla RC. Activation of the human transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci USA. 1994;91:1309-1313.
12. Folgero T, Bertheussen K, Lindal S, Torbergsen T, Oian P. Mitochondrial disease and reduced sperm motility. Hum Reprod. 1993;8:1863-1868.
13. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr. 1994;14: 535-568.
14. Wallace DC, Lott MT, Lezza AMS, Seibel P, Voljavec AS, Shoffner JM. Mitochondrial DNA mutations associated with neuromuscular disease: analysis and diagnosis using the polymerase chain reaction. Pediatr Res. 1990;28:525-528.
15. Hayashi J-I, Ohta S, Kagawa Y, et al. Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction: functional integrity of mitochondrial DNA from aged subjects. J Biol Chem. 1994;269:6678-6683.
16. Wallace DC, Singh G, Lott MI, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
17. Schon EA, Hirano M, DiMauro S. Mitochondrial encephalomyopathies: clinical and molecular analysis. J Bioenerg Biomembr. 1994;24:291-299.
18. DeSalle R, Williams AK, George M. Isolation and characterization of animal mitochondrial DNA. Methods Enzymol. 1993;224:176-204.
19. Kim YL, Brown MD, Wallace DC. Single-strand conformation polymorphism analysis for detection of point mutations in the mitochondrial DNA. Anal Biochem. 1995;224:608-611.
20. Wang H, Fliegel L, Cass CE, et al. Quantitation of mitochondrial DNA in heteroplasmic fibroblasts with competitive PCR. BioTechniques. 1994;17:76-82.
21. Hegler J, Bittner D, Boiteux S, Epe B. Quantification of oxidative DNA modifications in mitochondria. Carcinogenesis. 1993;14:2309-2312.
22. Zullo S, Kennedy JL, Gelernter J, et al. Eliminating mitochondrial DNA competition for nuclear DNA primers. PCR Methods Appl. 1993;3:39-45.
23. Fukuda M, Wakasugi S, Tsuzuki T, Nomiyama H, Shimada K. Mitochondrial DNA-like sequences in the human nuclear genome: characterization and implications in the evolution of mitochondrial DNA. J Mol Biol. 1985;186:257-266.
24. Wenger RH, Gassmann M. Mitochondria contaminate databases. Trends Genet. 1995;11:167-168.
25. Farkas DH, Kaul KL, Wiedbrauk DL, Kiechle FL. Specimen collection and storage for diagnostic molecular pathology investigation. Arch Pathol Lab Med. 1996;120:591-596.
26. Kiechle FL, Chambers LM, Cox RS, et al, eds. Patient Preparation and Specimen Handling, Fascicle VII: Reference Guide for Diagnostic Molecular Pathology and Flow Cytometry. Northfield, III: College of American Pathologists. In press.
27. Mazziotta MRM, Ricci E, Bertini E, et al. Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr. 1992;121:896-901.
28. Moraes CT, Ricci E, Arnaudo E, Bonilla E, DiMauro S, Schon EA. Quantitative defects of mitochondrial DNA. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York., NY: Raven Press Ltd; 1993:97-108.
29. Moraes CT. Mitochondrial depletion in human pathology. Int Pediatr. 1993;8:40-44.
30. Larsson N-G, Oldfors A, Holme E, Clayton DA. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun. 1994;200:1374-1381.
31. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991;337:508-510.
32. Lewis W, Simpson JF, Meyer RR. Cardiac mitochondrial DNA polymerase-δ is inhibited competitively and noncompetitively by phosphorylated zidovudine. Circ Res. 1994;74:344-348.
33. Zhang H, Cooney DA, Sreenath A, et al. Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content. Mol Pharmacol. 1994;46:1063-1069.
34. Poulton J, Sewry C, Potter CG, et al. Variation in mitochondrial DNA levels in muscle from normal controls: is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome? J Inherit Metab Dis. 1995;18: 4-20.
35. Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S, D'Agati V. Mitochondrial DNA deletion: a cause of chronic tubulointerstitial nephropathy. Kid Int. 1994;45:1388-1396.
36. Ponzetto C, Bresolin N, Bordoni A, et al. Kearns-Sayre syndrome: different amounts of deleted mitochondrial DNA are present in several autoptic tissues. J Neurol Sci. 1990;96:207-210.
37. Brown MD, Wallace DC. Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr. 1994;26:273-289.
38. Baerlocher KE, Feldges A, Weissert M, Simonsz HJ, Rötig A. Mitochondrial DNA deletion in an 8-year-old boy with Pearson syndrome. J Inherit Metab Dis. 1992;15:327-330.
39. Nakase H, Moraes CT, Rizzuto R, Lombes A, DiMauro S, Sehou EA. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am J Hum Genet. 1990;46:418-427.
40. Superti-Furga A, Schoenle E, Tuchschmid P, et al. Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA. Eur J Pediatr. 1993;152:44-50.
41. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 1989;320:1293-1299.
42. Poulton J, Holt IG. Mitochondrial DNA: does more lead to less? Nat Genet. 1994;8:313-315.
43. Poulton J, Morten KJ, Weber K, Brown GK, Bindoff L. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome? Hum Mol Genet. 1994;3:947-951.
44. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC. Mitochondrial diabetes revisited. Nat Genet. 1994;7:458-459.
45. Fromenty B, Grimbert S, Mansouri A, et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology. 1995;108:193-200.
46. Rötig A, Lormier V, Chatelain P, et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest. 1993;16:527-530.
47. Bu X, Rotter JI. Wolfram syndrome: a mitochondrial-mediated disorder? Lancet. 1993;342:598-600.
48. Prelle A, Moggio M, Checcarelli N, et al. Multiple deletions of mitochondrial DNA in a patient with periodic attacks of paralysis. J Neurol Sci. 1993;117: 24-27.
49. Suomalainen A, Leinonen H, Peltonen L, Paetau A, Majander A, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet. 1992;340:1319-1320.
50. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature. 1989;339:309-331.
51. Checcarelli N, Prelle A, Moggio M, et al. Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J Neurol Sci. 1994;123:74-79.
52. Hsuh R-H, Hou J-H, Hsu HS, Wei Y-H. Age-dependent respiratory function decline and DNA deletions in human muscle mitochondria. Biochem Mol Biol Int. 1994;32:1009-1022.
53. Lee H-C, Pang C-Y, Hsu H-S, Wei Y-H. Differential accumulation of 4,977 bp deletion in mitochondrial DNA of various tissues in human aging. Biochim Biophys Acta. 1994;1226:37-43.
54. Yen T-C, King K-L, Lee H-C, Yeh S-H, Wei Y-H. Age-dependent increase of mitochondrial DNA deletions together with lipid peroxides and superoxide dismutase in human liver mitochondria. Free Radic Biol Med. 1994;16:207-214.
55. Pang C-Y, Lee H-C, Yang J-H, Wei Y-H. Human skin mitochondrial DNA deletions associated with light exposure. Arch Biochem Biophys. 1994;312:534-538.
56. Tatuch Y, Robinson BH. The mitochondrial DNA mutation 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun. 1993;192:124-128.
57. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993;50:1197-1208.
58. Wallace DC. Mitochondrial diseases: genotype versus phenotype. Trends Genet. 1993;9:128-133.
59. Harding AE, Halt IJ, Sweeney MG, Brockington M, Davis MB. Prenatal diagnosis of mitochondrial DNA 8993 T→G disease. Am J Hum Genet. 1992;50: 629-633.
60. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic DNA mutation (T→G) can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992;50:852-858.
61. Suomalainen A. PCR in the analysis of mutations in mitochondrial DNA. Ann Med. 1992;24:201-205.
62. Santorelli FM, Shanske S, Jain KD, Tick D, Schon EA, DiMauro S. A T→C mutation at mt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology. 1994;44:972-974.
63. Flanigan KM, Johns DR. Association of the 11778 mitochondrial DNA mutation and demyelinating disease. Neurology. 1993;43:2720-2722.
64. Heher KL, Johns DR. A maculopathy associated with the 15257 mitochondrial DNA mutation. Arch Ophthalmol. 1993;111:1495-1499.
65. Oostra RJ, Bolhuis PA, Wijburg FA, Zorn-Ende G, Bleeker-Wagemakers EM. Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome. J Med Genet. 1994;31:280-286.
66. Brown MD, Wallace DC. Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr. 1994;26:273-289.
67. Huoponen K, Lamminen T, Juronen V, Aula P, Nikoskelainen E, Sarontaus M-L. The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy. Hum Genet. 1993;92:379-384.
68. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit to gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA. 1994;91:6206-6210.
69. Brown MD, Yang C-C, Trounce I, Torroni A, Lott MT, Wallace DC. A mitochondrial DNA variant, identified in Leber hereditary optic neuropathy patients, which extends the amino acid sequence of cytochrome c oxidase subunit I. Am J Hum Genet. 1992;51:378-385.
70. Howell N, Kubacka I, Halvorson S, Howell B, McCullough DA, Mackey D. Phylogenetic analysis of the mitochondrial genomes from Leber hereditary optic neuropathy pedigrees. Genetics. 1995;140:285-302.
71. Howell N. Mitochondnal gene mutations and human diseases: a prolegomenon. Am J Hum Genet. 1994;55:219-224.
72. Mashima Y, Hiida Y, Oguchi Y, Kudoh J, Shimizu N. High frequency of mutations at position 11778 in mitochondrial ND4 gene in Japanese families with Leber's hereditary optic neuropathy. Hum Genet. 1993;92:101-102.
73. Norby S. Mutation-specific PCR: a rapid and inexpensive diagnostic method, as exemplified by mitochondrial DNA analysis in Leber's hereditary optic neuropathy. DNA Cell Biol. 1993;12:549-552.
74. Norby S. Screening for the two most frequent mutations in Leber's hereditary optic neuropathy by duplex PCR based on allele-specific amplification. Hum Mutat. 1993;2:309-313.
75. Leu(UUR) gene an etiologic hot spot? J Clin Invest. 1993;92:2906-2915.
76. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993;50:1197-1208.
77. Lestienne P. Mitochondrial DNA mutations in human diseases: a review. Biochimie. 1992;74:123-130.
78. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993;2:2081-2087.
79. Lys and premature translation termination. Nat Genet. 1995;10:47-55.
80. Moudy AM, Handran SD, Goldberg MP, et al. Abnormal calcium hemeostasis and mitochondrial polarization in a human encephalomyopathy. Proc Natl Acad Sci USA. 1995;92:729-733.
81. Clarke LA. Mitochondrial disorders in pediatrics. Pediatr Clin N Am. 1992;39:319-334.
82. Mosewich RK, Donat JR, DiMauro S, et al. The syndrome of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes presenting without stroke. Arch Neurol. 1993;50:275-278.
83. Schröder JM. Neuropathy associated with mitochondrial disorders. Brain Pathol. 1993;3:177-190.
84. Ozawa T, Tanaka M, Ino H, et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun. 1991;176:938-946.
85. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus with a mutation of mitochondrial DNA. N Engl J Med. 1994;330:962-968.
86. Pro gene. Neurology. 1994;44:975-977.
87. Seibel P, Flier A, Kottlors M, Reichmann H. A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalomyopathies. Biochem Biophys Res Commun. 1994;200:938-942.
88. Houshmand M, Larsson N-G, Holme E, Oldfors A, Tulinius MH, Andersen O. Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochim Biophys Acta. 1994;1226:49-55.
89. Seibel P, Trappe J, Villani G, Klopstock T, Papa S, Reichmann H. Transfection of mitochondrial DNA diseases: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res. 1995;23:10-17.